rs145082938

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004035.7(ACOX1):​c.80C>T​(p.Pro27Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00207 in 1,611,258 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P27S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0063 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 24 hom. )

Consequence

ACOX1
NM_004035.7 missense

Scores

5
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 4.24

Publications

5 publications found
Variant links:
Genes affected
ACOX1 (HGNC:119): (acyl-CoA oxidase 1) The protein encoded by this gene is the first enzyme of the fatty acid beta-oxidation pathway, which catalyzes the desaturation of acyl-CoAs to 2-trans-enoyl-CoAs. It donates electrons directly to molecular oxygen, thereby producing hydrogen peroxide. Defects in this gene result in pseudoneonatal adrenoleukodystrophy, a disease that is characterized by accumulation of very long chain fatty acids. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
TEN1 (HGNC:37242): (TEN1 subunit of CST complex) C17ORF106, or TEN1, appears to function in a telomere-associated complex with STN1 (OBFC1; MIM 613128) and CTC1 (C17ORF68; MIM 613129) (Miyake et al., 2009 [PubMed 19854130]).[supplied by OMIM, Nov 2009]
TEN1-CDK3 (HGNC:44420): (TEN1-CDK3 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring TEN1 telomerase capping complex subunit homolog (S. cerevisiae) and cyclin-dependent kinase 3 (CDK3) genes. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is therefore unlikely to produce a protein product. [provided by RefSeq, Oct 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00561586).
BP6
Variant 17-75978994-G-A is Benign according to our data. Variant chr17-75978994-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 235759.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00634 (966/152288) while in subpopulation AFR AF = 0.0186 (773/41560). AF 95% confidence interval is 0.0175. There are 5 homozygotes in GnomAd4. There are 450 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACOX1NM_004035.7 linkc.80C>T p.Pro27Leu missense_variant Exon 1 of 14 ENST00000293217.10 NP_004026.2
TEN1NM_001113324.3 linkc.-524G>A upstream_gene_variant ENST00000397640.6 NP_001106795.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACOX1ENST00000293217.10 linkc.80C>T p.Pro27Leu missense_variant Exon 1 of 14 1 NM_004035.7 ENSP00000293217.4
TEN1ENST00000397640.6 linkc.-524G>A upstream_gene_variant 1 NM_001113324.3 ENSP00000380762.1

Frequencies

GnomAD3 genomes
AF:
0.00627
AC:
954
AN:
152170
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0184
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00412
Gnomad ASJ
AF:
0.0127
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.000867
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00328
AC:
818
AN:
249350
AF XY:
0.00287
show subpopulations
Gnomad AFR exome
AF:
0.0184
Gnomad AMR exome
AF:
0.00428
Gnomad ASJ exome
AF:
0.0127
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0000985
Gnomad NFE exome
AF:
0.00125
Gnomad OTH exome
AF:
0.00883
GnomAD4 exome
AF:
0.00162
AC:
2365
AN:
1458970
Hom.:
24
Cov.:
31
AF XY:
0.00162
AC XY:
1177
AN XY:
726000
show subpopulations
African (AFR)
AF:
0.0183
AC:
611
AN:
33474
American (AMR)
AF:
0.00423
AC:
189
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0114
AC:
298
AN:
26130
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00161
AC:
139
AN:
86256
European-Finnish (FIN)
AF:
0.0000791
AC:
4
AN:
50588
Middle Eastern (MID)
AF:
0.0285
AC:
164
AN:
5764
European-Non Finnish (NFE)
AF:
0.000646
AC:
718
AN:
1111972
Other (OTH)
AF:
0.00399
AC:
241
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
165
330
494
659
824
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00634
AC:
966
AN:
152288
Hom.:
5
Cov.:
32
AF XY:
0.00604
AC XY:
450
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0186
AC:
773
AN:
41560
American (AMR)
AF:
0.00412
AC:
63
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0127
AC:
44
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4826
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10628
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.000867
AC:
59
AN:
68020
Other (OTH)
AF:
0.00568
AC:
12
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
45
90
135
180
225
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00288
Hom.:
6
Bravo
AF:
0.00751
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.0186
AC:
82
ESP6500EA
AF:
0.00128
AC:
11
ExAC
AF:
0.00328
AC:
398
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00229
EpiControl
AF:
0.00237

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Acyl-CoA oxidase deficiency Benign:4
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 11, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jan 01, 2019
Institute of Human Genetics, University of Leipzig Medical Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Aug 16, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 28, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.42
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.47
.;T;.
Eigen
Benign
0.025
Eigen_PC
Benign
0.16
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.90
D;D;D
MetaRNN
Benign
0.0056
T;T;T
MetaSVM
Benign
-0.87
T
MutationAssessor
Benign
1.9
M;M;.
PhyloP100
4.2
PrimateAI
Benign
0.48
T
PROVEAN
Uncertain
-3.5
D;D;.
REVEL
Benign
0.11
Sift
Benign
0.090
T;T;.
Sift4G
Benign
0.20
T;T;.
Polyphen
0.0
B;B;.
Vest4
0.17
MVP
0.70
MPC
0.66
ClinPred
0.053
T
GERP RS
3.8
PromoterAI
-0.028
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.19
gMVP
0.66
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145082938; hg19: chr17-73975075; API